Financial Navigation Study Among Young Adult Blood Cancer Survivors
Completed · Not applicable
Conditions studied: Survivorship, Cancer, Financial Stress
In brief
Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.
Key facts
- Study ID
- NCT05620979
- Run by
- Tufts Medical Center
- People needed
- 130
- Starts
- 2022-02-14
- Expected to finish
- 2023-11-23
- Last updated by the study team
- 2024-11-21
Who can join
Age: 18 and older, up to 39. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma, myelodysplastic syndrome, or myeloproliferative neoplasm)
- Current age between 18-39 years old
- Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood (18-36 years of age)
- At least three years post blood cancer diagnosis
- Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer medication with stable disease
- Off treatment for a second cancer (non-blood cancer) or on a stable long-term regimen, such as hormone therapy or hormone replacement therapy
- Primary residence in United States
- Able to understand and read the English language
You may not qualify if…
- On parent or guardian's insurance
Where it is running
- Children's Hospital Los Angeles — Los Angeles, California, United States
- University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital) — Los Angeles, California, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Bon Secours Mercy Health System — Greenville, South Carolina, United States
- MD Anderson — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.